Texte intégral de l'article
 
   
  Version PDF

Magnesium and cancer: a dangerous liason


Magnesium Research. Volume 24, Numéro 3, 92-100, September 2011, European Magnesium Meeting - EUROMAG Bologna 2011. Guest Editors: F.I. Wolf and S. Iotti

DOI : 10.1684/mrh.2011.0285

Summary  

Auteur(s) : Sara Castiglioni, Jeanette A.M. Maier, Università di Milano, Dipartimento di Scienze Cliniche Luigi Sacco, Milano, Italy.

Illustrations



Figure 1 Neoplastic cells tend to have high intracellular concentrations of magnesium, which contribute to the regulation of various metabolic pathways and of systems involved in DNA repair, thus providing a selective advantage for the transformed cells. The figure also links the effects of high intracellular concentrations of magnesium on cell functions to some hallmarks of cancer as highlighted by Hanahan and Weinberg [14, 15].



Figure 2 In mice, magnesium deficiency participates both in early and in late phases of tumorigenesis. Initiation: low magnesium promotes oxidative stress and inflammation, which generate genetic instability and increases the risk of mutations. Mutations might generate the so-called “initiated” cell, which is potentially capable of triggering a tumor. Progression: once the tumor has developed, the persistence of oxidative stress and inflammation might generate further mutations that facilitate metastatic spreading, in the face of an inhibition of primary tumor growth.


Copyright © 2007 John Libbey Eurotext - Tous droits réservés